Close Menu

influenza

NEW YORK (GenomeWeb) — Alere said today that it has entered into a contract with the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) to develop diagnostic countermeasures for pandemic influenza.

NEW YORK (GenomeWeb News) — Cepheid said today that it has received CE marking for Xpert Flu/RSV XC, an on-demand molecular test for determination of influenza A and B infection and differentiation of respiratory syncytial virus infection.

NEW YORK (GenomeWeb) — IMDx said today that it has received three additional licenses for sale and distribution of its molecular tests for the Abbott m2000 platform outside the US and EU.

NEW YORK (GenomeWeb) — Alere said today that it has received US Food and Drug Administration Clearance for the Alere i Influenza A&B test.

NEW YORK (GenomeWeb) — Early-stage molecular diagnostics developer Mesa Tech International has been awarded $1 million from the National Institutes of Health to further develop its low-cost nucleic acid testing device for respiratory disease diagnosis.

NEW YORK (GenomeWeb News) – In Nature Genetics, researchers from the US Department of Energy's Joint Genome Institute, the HudsonAlpha Institute for Biotechnology, and elsewhere reported on res

NEW YORK (GenomeWeb) – Johns Hopkins University today announced a contract from the National Institutes of Health to create a center focused on developing methods, including the use of genomic technologies, to identify and track global influenza outbreaks.

Roche's acquisition of privately held Boston-area molecular diagnostics developer Iquum, announced earlier this week, is expected to fill a hole in Roche's product portfolio, gi

NEW YORK (GenomeWeb News) — Roche said today that it has acquired Iquum, a privately held company developing point-of-care molecular diagnostics.

Researchers from Seattle Children's Hospital, working with Sony subsidiary Micronics, are developing a point-of-care diagnostic to identify and track new influenza strains under a five-year, $5.3 million grant from the National Institute of Allergy and Infectious Diseases.

Pages

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.